RXRX Projected Dividend Yield
Cl A/Recursion Pharmaceuticals Inc ( NASDAQ : RXRX )Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Co. to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. Co. integrates physical and digital components as iterative loops of atoms and bits scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate in silico hypotheses into validated insights and novel chemistry. Its clinical programs include REC-994, REC-2282, REC-4881 and REC-3964. 20 YEAR PERFORMANCE RESULTS |
RXRX Dividend History Detail RXRX Dividend News RXRX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |